The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
No Thumbnail Available
Date
2004-04-16
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
BCG (Bacillus Calmette Guerin) vaccine remains a highly controversial method of preventing tuberculosis and leprosy despite more than eighty years of use. The protective effect against tuberculosis observed in various studies ranged from -56% to 98%. Case-control studies carried out at Nagpur reported moderate effectiveness of BCG vaccination in prevention of tuberculosis. Its effectiveness was higher against extra-pulmonary tuberculosis. The summary protective effects obtained from meta-analysis of trials, cohort studies and case-control studies of BCG vaccination and tuberculosis were 51 (33-64), 76 (63-85), and 65 (57-72) percent respectively. The case-control studies carried out at Nagpur also demonstrated a significant protective association between BCG vaccination and leprosy. The summary protective effects obtained from meta-analysis of trials, cohort studies and case-control studies of BCG vaccination and leprosy were 43 (27-55), 62 (53-69), and 59 (46-68) percent respectively. The results of the current study and systematic review thus supported arguments favoring use of BCG vaccine for prevention of tuberculosis and leprosy.
Description
Keywords
Citation
Zodpey SP. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy. Indian Journal of Public Health. 2004 Apr-Jun; 48(2): 70-7